342 The Implications of High Expression of VISTA, a Negative Check Point Regulator, on Prognosis Across Malignant Solid Tumors: a Systematic Review and Meta-Analysis
OBJECTIVES/GOALS: Targeting the V-domain immunoglobulin suppressor of T cell activation (VISTA) signaling pathway has been suggested as a promising approach for overcoming resistance to current immune checkpoint therapies in advanced cancer. This review will synthesize the rapidly-expanding literatu...
Main Authors: | Alexander S Martin, Yana V Salei, Mumtu Lalla, Paola Sebastiani, Rebecca A. Morin, Robert E Martell, Ludovic Trinquart |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-04-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866123003862/type/journal_article |
Similar Items
-
The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
by: Nour el Imane Issam Salah, et al.
Published: (2023-08-01) -
VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
by: Xi Cao, et al.
Published: (2021-01-01) -
VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
by: Xing Huang, et al.
Published: (2020-06-01) -
Check-worthy claim detection across topics for automated fact-checking
by: Amani S. Abumansour, et al.
Published: (2023-05-01) -
RPK 342 - Sejarah Perancangan
by: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Published: (1995)